Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 12,851

Document Document Title
WO/2013/014267A1
A process is provided for preparing C8-C22 acyl amido compounds via reaction in a polyol (molecular weight 76 to 300) of interesterifying a fatty acid ester with an amino compound or salt thereof. The resultant mass of material will have...  
WO/2013/014265A1
A reagent composition for forming fatty acyl amido surfactants is provided which includes an alkali metal or alkaline earth metal salt of an amino compound; a polyol of molecular weight ranging from 76 to 300; and no more than 10% water.  
WO/2013/010502A1
Disclosed are an acid addition salt of prasugrel, a preparation method therefor and a use thereof. The preparation method is: adding prasugrel and hydroxyl-substituted benzenesulfonic acid to an organic solvent, stirring and dissolving, ...  
WO/2012/148143A3
The present invention relates to an organic sulfonic compound and a preparation method therefor, a dopant having the compound, and a conductive polymer complex having the dopant, and more specifically, to a dopant having a derivative com...  
WO/2013/008700A1
An actinic ray-sensitive or radiation-sensitive resin composition, includes: (A) a compound represented by the following formula (I); and (B) a resin: wherein X represents an oxygen atom, a sulfur atom or -N(Rx)-; each of R1 to R8 and Rx...  
WO/2012/145274A3
Provided herein are inter alia novel compositions and methods having application in the field of enhanced oil recovery. In particular, the large hydrophbe compounds and mixtures thereof presented herein can be used, inter alia, for the r...  
WO/2013/000571A1
A surfactant composition comprising alkylarylsulfonate molecules wherein more than 30 wt.% of the alkylarylsulfonate molecules of the surfactant composition are one or more species of the formula: [R - X - Ar (SO3)-]a [Mn+]b wherein: X i...  
WO/2012/135278A3
There are disclosed olefinic acid amplifier triggers and methods of using these compositions in, for example, photolithography.  
WO/2012/135286A3
There are disclosed sulfonic acid precursor compositions, as are methods of using these compositions in, for example, photolithography. Other embodiments are also disclosed.  
WO/2012/147037A3
Isolation of Naphthalene Sulphonic Acid Compounds is achieved with acidification of alkali fusion mixture with dilute sulphuric acid to precipitation at the predetermined conditions temperature, time and pH and Naphthalene Sulphonic Acid...  
WO/2012/173235A1
A compound represented by formula (I) [wherein R1 represents a hydrocarbon group having 1-10 carbon atoms, and Z represents a hydrocarbon group having 1-10 carbon atoms or a cyano group, wherein R1 and Z may be bound to each other to for...  
WO/2012/173148A1
The present invention relates to a conductive polymer precursor represented by general formula (1). (In formula (1), R1 to R4 are each independently selected from among the group comprising a hydrogen atom, a straight chain or branched c...  
WO/2012/110833A3
The present invention relates to fluorescence lifetime modulators, conjugates comprising fluorescence lifetime modulators moieties and methods of making them. The present invention further relates to the use of the fluorescence lifetime ...  
WO/2012/169468A1
Provided is a novel method for producing a cyclopentanone compound. The present invention is a method for producing a cyclopentanone compound represented by formula (I), comprising the steps of: reacting a compound represented by formula...  
WO/2012/169555A1
In order to manufacture an intermediate that makes it possible to obtain a cyclic alcohol compound stereoselectively, the method for manufacturing an oxetane compound according to the invention reacts a compound expressed by formula (I) ...  
WO/2012/165314A1
The present invention provides an amide compound useful as a therapeutic agent for hypertension and the like. The present invention provides a compound represented by general formula (I) [wherein R1: an optionally substituted adamantyl g...  
WO/2012/163799A1
The present invention relates to a novel enantioselective method of preparing (S)- and (R)-enantiomers of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-5 methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonami de, to novel inte...  
WO/2012/163781A1
The invention relates to a compound, comprising at least three functionalities, that is (a) a sulfonate or sulfate group of the formula - (O)d-SO3M with d = 0 or 1 and M = hydrogen or a monovalent metal cation or the corresponding fracti...  
WO/2012/160187A1
The present invention relates to amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives, in particular the compounds of formula 1, 2, 3, 4, 5 or 6, and their medical use, including their use in the t...  
WO/2012/160186A1
The present invention relates to oxygenated amino or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives, in particular the compounds of formula 1, 2, 3, 4, 5 or 6, and their medical use, including their us...  
WO/2012/156693A1
Processes for the preparation of the compound of formula (II) and intermediate compounds for use in the processes.  
WO/2012/112828A4
The invention is directed to mixtures comprising C10-C14 linear alkylphenyl sulfonates with alkyl groups having a biobased content of at least 50%. These C10-C14 linear alkylphenyl sulfonates are used in consumer product cleaning and per...  
WO/2012/118973A3
The claimed invention meets these and other objects by providing a method of preparing a metal salt of a dialkyl ester of 5-sulfoisophthalic acid. Broadly speaking, the method provides for the contacting of a dialkyl ester of 5-sulfoisop...  
WO/2012/150204A1
This invention relates to novel precursors suitable for 18F radiolabeling of glutamate derivatives, methods for preparing such compounds and its intermediates, compositions comprising such compounds, kits comprising such compounds or com...  
WO/2012/150220A1
This invention relates to novel compounds suitable for labeling by 18F and to the corresponding 18F labeled compounds themselves, 19F-fluorinated analogues thereof and their use as reference standards, methods of preparing such compounds...  
WO/2012/151058A1
This invention discloses (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitarnin D3 analogs, and especially (20S)-25,26,27-trinor-24-|(p-methyiphenylsulfonate)-vitamin D3, its biological activities, and pharmaceutical uses therefor. This...  
WO/2012/146371A1
The present invention relates to novel solid forms of agomelatine (I), specifically novel pharmaceutically acceptable cocrystals thereof, as well as to methods of preparing them. Three pharmaceutically acceptable cocrystals of (I) that h...  
WO/2012/147944A1
The present invention provides a method for producing a compound represented by general formula (1) (wherein R1, R2, R3, R10-R14, A1-A3, n1 and n2 are as defined in the description), which is characterized by reacting a compound represen...  
WO/2012/148143A2
The present invention relates to an organic sulfonic compound and a preparation method therefor, a dopant having the compound, and a conductive polymer complex having the dopant, and more specifically, to a dopant having a derivative com...  
WO/2012/142698A1
Compounds of formula (I) : wherein A, m, n, R1, X, Y, R2, R3, R4, R5 and R6, as defined herein are provided as useful for the treatment of cancer or for the manufacture of anti-cancer agents.  
WO/2012/145274A2
Provided herein are inter alia novel compositions and methods having application in the field of enhanced oil recovery. In particular, the large hydrophbe compounds and mixtures thereof presented herein can be used, inter alia, for the r...  
WO/2012/144306A1
The present invention provides: a nonaqueous electrolyte solution which is capable of improving electrochemical characteristics over a wide temperature range; an electricity storage device which uses the nonaqueous electrolyte solution; ...  
WO/2012/142927A1
A method for purification of calcium ion channel blocker medicament of dihydropyridine type and pharmaceutically acceptable salts thereof through the ultrasonic crystallization technology and direct preparation of nanoparticles thereof.  
WO/2012/082718A3
The present invention relates to purified 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt thereof, and a method for preparing such compound. The compound has at least 90% (w/w) purity. The present invention is also d...  
WO/2012/071102A3
A method of buffering a chemical or biological composition, comprising adding to the composition an effective buffering amount of at least one protonated or un-protonated amine-quaternary ammonium compound having a general formula(CI)d w...  
WO/2012/136761A1
The present invention relates to a process for the preparation of the mono sodium salt of the derivative 3,5-diiodo-O-[3-iodo-4-(sulphooxy)phenyl]-L- tyrosine (T3S) by starting from the corresponding phenolic compound, in the presence of...  
WO/2012/134925A1
The present disclosure is directed to a reactive ester agent for conjugating a click-reactive group to a carrier molecule or solid support. The reactive ester agent has the general formula IA, wherein the variables R1, R2, R3, Ra and L a...  
WO/2012/135278A2
There are disclosed olefinic acid amplifier triggers and methods of using these compositions in, for example, photolithography.  
WO/2012/130850A1
The invention relates to substituted bridged diphenyl derivatives, which contain (i) at least one dialkyl triazenyl group and (ii) at least one selected oxy carboxylic acid group per molecule, to the salts thereof, to the solvates thereo...  
WO/2012/132269A1
The present invention provides a novel diamine compound that contains a sulfonic acid group and is represented by formula (1), and a method for producing the same. This compound has a fluorene backbone including a sulfonic acid group or ...  
WO/2012/134464A1
Disclosed is a method for improving filtration in the preparation of an alkaline earth metal alkyltoluene sulfonate concentrate by selectively controlling the meta, ortho, para isomer distribution of the alkyl group of the alkyltoluene p...  
WO/2012/135286A2
There are disclosed sulfonic acid precursor compositions, as are methods of using these compositions in, for example, photolithography. Other embodiments are also disclosed.  
WO/2010/106550A3
The present invention is directed to an novel, industrially viable and cost effective process for preparation of substantially pure N-[[trans-4-(l-methylethyl) cyclohexyl] carbonyl]-D- phenylalanine commonly known as Nateglinide.  
WO/2012/126088A1
A method for preparing docosahexaenoic acid (DHA). The method comprises coupling a compound represented by Formula I with a compound represented by Formula II followed by partial hydrogenation to obtain a compound represented by Formula ...  
WO/2012/118973A2
The claimed invention meets these and other objects by providing a method of preparing a metal salt of a dialkyl ester of 5-sulfoisophthalic acid. Broadly speaking, the method provides for the contacting of a dialkyl ester of 5-sulfoisop...  
WO/2012/112828A1
The invention is directed to mixtures comprising C10-C14 linear alkylphenyl sulfonates with alkyl groups having a biobased content of at least 50%. These C10-C14 linear alkylphenyl sulfonates are used in consumer product cleaning and per...  
WO/2012/110833A2
The present invention relates to fluorescence lifetime modulators, conjugates comprising fluorescence lifetime modulators moieties and methods of making them. The present invention further relates to the use of the fluorescence lifetime ...  
WO/2012/103799A1
Disclosed are (2R,3R)-3-(3-substituted phenyl)-2-methyl-n-pentanamide compounds shown as formula I, their preparation methods thereof, wherein the substituents are described in the description, and their uses in the manufacture of Tapent...  
WO/2012/105586A1
This perfluorobutane sulfonyl fluoride has a perfluorosulfolane content of 100 ppm or less on a mass basis. This potassium perfluorobutane sulfonate salt has a potassium 1,1,2,2,3,3,4,4-octafluorobutane sulfonate salt content of 100 ppm ...  
WO/2012/050922A3
Gastric retentive dosage forms for sustained reiease of acamprosate are described which may allow once- or twice-daily dosing for both acute and long-term treatment of a disorder including alcohol dependence, tinnitus, sleep apnea, Parki...  

Matches 551 - 600 out of 12,851